All In Biotech

Free tool

FAERS Monitor: Pulmicort Flexhaler

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021949 or its brand name (Pulmicort Flexhaler, Budesonide). Reports on generic versions are filed under their own applications.

Reports

50,377

Serious

35,793

71% of reports

Hospitalization

17,535

Death reported

3,580

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea6,184
  • drug ineffective5,799
  • off label use5,418
  • asthma4,710
  • cough3,107
  • fatigue2,965
  • headache2,761
  • condition aggravated2,723
  • pneumonia2,606
  • diarrhoea2,588
  • nausea2,436
  • wheezing2,405
  • pyrexia2,113
  • pain2,097
  • malaise2,073

Reports by year received

View as table
YearReports
2004527
2005584
2006585
2007775
2008909
2009722
20101,068
20111,577
20121,994
20131,341
20141,610
20151,660
20161,859
20171,985
20182,525
20193,199
20203,777
20213,988
20224,322
20234,241
20244,186
20254,065
20262,875

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,003,782 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
asthmaSignal4,71018.117.673,358
wheezingSignal2,40517.616.936,227
coughSignal3,1074.74.58,967
dyspnoeaSignal6,1844.64.517,707
condition aggravatedSignal2,7233.83.65,555
pneumoniaSignal2,6063.43.34,397
off label useSignal5,4182.62.55,498
pyrexiaSignal2,1132.62.52,027
malaise2,0732.01.91,018
headache2,7611.81.81,090
drug ineffective5,7991.81.82,365
diarrhoea2,5881.71.6725
fatigue2,9651.61.5675
pain2,0971.41.4274
nausea2,4361.31.2160

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.